SRRA Annual Working Capital
$94.51 M
-$2.61 M-2.69%
31 December 2021
Summary:
As of February 5, 2025, SRRA annual working capital is $94.51 million, with the most recent change of -$2.61 million (-2.69%) on December 31, 2021. During the last 3 years, it has fallen by -$4.14 million (-4.20%).SRRA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRRA Quarterly Working Capital
$265.12 M
+$170.61 M+180.52%
31 March 2022
Summary:
As of February 5, 2025, SRRA quarterly working capital is $265.12 million, with the most recent change of +$170.61 million (+180.52%) on March 31, 2022. Over the past year, it has increased by +$164.34 million (+163.06%).SRRA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRRA Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.7% | +163.1% |
| 3 y3 years | -4.2% | +203.4% |
| 5 y5 years | +0.3% | +119.9% |
SRRA Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -34.6% | at high |
Sierra Oncology Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $265.12 M(+180.5%) |
| Dec 2021 | $94.51 M(-2.7%) | $94.51 M(+0.4%) |
| Sept 2021 | - | $94.09 M(+13.1%) |
| June 2021 | - | $83.21 M(-17.4%) |
| Mar 2021 | - | $100.78 M(+3.8%) |
| Dec 2020 | $97.12 M(+13.9%) | $97.12 M(-7.1%) |
| Sept 2020 | - | $104.50 M(-9.6%) |
| June 2020 | - | $115.64 M(-10.0%) |
| Mar 2020 | - | $128.47 M(+50.6%) |
| Dec 2019 | $85.29 M(-13.5%) | $85.29 M(+38.5%) |
| Sept 2019 | - | $61.60 M(-16.4%) |
| June 2019 | - | $73.66 M(-15.7%) |
| Mar 2019 | - | $87.37 M(-11.4%) |
| Dec 2018 | $98.65 M | $98.65 M(-11.3%) |
| Sept 2018 | - | $111.20 M(-7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | $119.95 M(-8.0%) |
| Mar 2018 | - | $130.35 M(+38.3%) |
| Dec 2017 | $94.25 M(-8.2%) | $94.25 M(-8.7%) |
| Sept 2017 | - | $103.28 M(-7.6%) |
| June 2017 | - | $111.74 M(-7.3%) |
| Mar 2017 | - | $120.58 M(+17.5%) |
| Dec 2016 | $102.63 M(-29.0%) | $102.63 M(-7.0%) |
| Sept 2016 | - | $110.37 M(-11.1%) |
| June 2016 | - | $124.17 M(-8.4%) |
| Mar 2016 | - | $135.49 M(-6.2%) |
| Dec 2015 | $144.46 M(+283.9%) | $144.46 M(-6.7%) |
| Sept 2015 | - | $154.79 M(+591.6%) |
| June 2015 | - | $22.38 M(-10.0%) |
| Mar 2015 | - | $24.87 M(-33.9%) |
| Dec 2014 | $37.63 M(+2310.6%) | $37.63 M |
| Dec 2013 | $1.56 M | - |
FAQ
- What is Sierra Oncology annual working capital?
- What is the all time high annual working capital for Sierra Oncology?
- What is Sierra Oncology annual working capital year-on-year change?
- What is Sierra Oncology quarterly working capital?
- What is the all time high quarterly working capital for Sierra Oncology?
- What is Sierra Oncology quarterly working capital year-on-year change?
What is Sierra Oncology annual working capital?
The current annual working capital of SRRA is $94.51 M
What is the all time high annual working capital for Sierra Oncology?
Sierra Oncology all-time high annual working capital is $144.46 M
What is Sierra Oncology annual working capital year-on-year change?
Over the past year, SRRA annual working capital has changed by -$2.61 M (-2.69%)
What is Sierra Oncology quarterly working capital?
The current quarterly working capital of SRRA is $265.12 M
What is the all time high quarterly working capital for Sierra Oncology?
Sierra Oncology all-time high quarterly working capital is $265.12 M
What is Sierra Oncology quarterly working capital year-on-year change?
Over the past year, SRRA quarterly working capital has changed by +$164.34 M (+163.06%)